has anyone looked to see how this price is calculated?

CJR I am trying, but much of it is still beyond my comprehension.

Seems to me that Kry deceides wether to sell (or not to sell) to CR at the 20 day weighted average. It would definetly be in our benefit to have a high average to lessen dilusion. Imo- they will have to announce that the deal is put in force. But there are 600M? shares out there for people to play with, so do we just have to cross our fingers and hope for the best price?

Think about this: Lets say they do not announce. Within 10 days a perspectus outlaying the deal is being received by the shareholders, the SP average will be ???? when over the following 20 days KRY becomes a hot topic?

*The A&F Agreement will further provide that following the closing contemplated by the A&F Agreement (“Closing”), CRRC will subscribe for that number of Crystallex’s common shares as is agreed to by the parties at a price per common share equal to the 20-trading day volume weighted average trading price of Crystallex’s common shares on the NYSE-AMEX ending on the date that is 30 days after Closing. The option is exercisable by Crystallex for a period of 30 days following Closing.

At the same time...........I'm going over the agreement and the .40 Cdn SP offer is mentioned all over the place and the uncertianty of how much will be bought @ .40 Cdn and for how long, just ties up the SP there until the permit is granted, Imo. I hope I am wrong about that.

*CRRC shall have the option at any time to convert all or any portion of the Note Facility intocommon shares of Crystallex at a price of Cdn$0.40 per common share on or before the datewhich is 5 years following the date of the Note Facility.................................................

*obtaining approval of the Transactions by the shareholders ofCrystallex (including, without limitation, the conversion of the Note Facility and the Initial Loan intocommon shares of Crystallex at a price of Cdn$0.40 per common share).....................................................

*the Initial Loan was extended and, subject to receipt of requisite stock exchange and shareholder approvals, CRRC will have the right to cause the conversion of any amount of the Initial Loan then outstanding into common shares of Crystallex at a price of Cdn$0.40 per share.......................................................

HB